Assessing compliance with national comprehensive cancer network guidelines for elderly patients with stage III colon cancer: The fox chase cancer center partners' initiative

Clinical Colorectal Cancer

Volumn 10, Issue 2, 2011, Pages 113-116

  O'Grady, Margaret A ^a   Slater, Elyse ^a   Sigurdson, Elin R ^a   Meropol, Neal J ^b   Weinstein, Alan ^c   Lusch, Charles J ^d   Sein, Elaine ^a   Keeley, Patricia ^a   Miller, Bonnie ^a   Engstrom, Paul F ^a   Cohen, Steven J ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^c Virtua Fox Chase Cancer Program   (United States)

^d READING HOSPITAL AND MEDICAL CENTER   (United States)

Author keywords

Colon cancer; Community oncology; Gerontologic oncology; Performance improvement; Quality

Indexed keywords

CAPECITABINE; CARCINOEMBRYONIC ANTIGEN; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; OXALIPLATIN;

ABDOMEN; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER STAGING; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; COLON CANCER; COLONOSCOPY; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DAILY LIFE ACTIVITY; GERIATRIC PATIENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIFE EXPECTANCY; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; NEUROPATHY; PELVIS; PRACTICE GUIDELINE; THORAX RADIOGRAPHY;

EID: 79959372001     PISSN: 15330028     EISSN: 19380674     Source Type: Journal    
DOI: 10.1016/j.clcc.2011.03.007     Document Type: Article

References (24)

1. André T, Boni C, Mounedji-Boudiaf L, et al. Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer. N Engl J Med 2004; 350:2343-51. (Pubitemid 38702845)
2. Kuebler JP, Wieand HS, O'Connell MJ, et al. Oxaliplatin combined with weekly bolus fluorouracil and leucovorin as surgical adjuvant chemotherapy for stage II and III colon cancer: results from NSABP C-07. J Clin Oncol 2007; 25:2198-204. (Pubitemid 46954643)
3. André T, Boni C, Navarro M, et al. Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial. J Clin Oncol 2009; 27:3109-16.
4. Yancik R. Population aging and cancer: a cross national problem. Cancer J 2005; 11:437-41.
5. Extermann M. Interaction between comorbidity and cancer. Cancer Contr 2007; 14:13-22. (Pubitemid 46168962)
6. Ferrucci L, Balducci L. Anemia of aging: the role of chronic inflammation and cancer. Semin Hematol 2008; 45:242-9.
7. Higman SA, McKay FJ, Engstrom PF, et al. Fox Chase Network: Fox Chase Cancer Center's community hospital affiliation program. Oncologist 2000; 5:329-35. (Pubitemid 30666480)
8. O'Grady MA, Gitelson E, Swaby R, et al. Development and implementation of a medical oncology quality improvement tool for a regional community oncology network: The Fox Chase Cancer Center Partners Initiative. J Natl Compr Canc Netw 2007; 5:875-82. (Pubitemid 350069529)
9. NCCN 2006, version 2, Guidelines for Colon Cancer, 11/15/05 National Comprehensive Cancer Network.
10. Sanoff HK, Bleiberg H, Goldberg RM. Managing older patients with colorectal cancer. J Clin Oncol 2007; 25:1891-7. (Pubitemid 46854423)
11. Hutchins LF, Unger JM, Crowley JJ, et al. Underrepresentation of patients 65 years of age or older in cancer-treatment trials. N Engl J Med 1999; 341:2061-7. (Pubitemid 30035956)
12. Murthy VH, Krumholz HM, Gross CP. Participation in cancer clinical trials: race-, sex-, and age-based disparities. JAMA 2004; 291:2720-6. (Pubitemid 38725421)
13. Sargent DJ, Goldberg RM, Jacobson SD, et al. A pooled analysis of adjuvant chemotherapy for resected colon cancer in elderly patients. N Engl J Med 2001; 345: 1091-7.
14. Goldberg RM, Tabah-Fisch I, Bleiberg H, et al. Pooled analysis of safety and efficacy of oxaliplatin plus fluorouracil/leucovorin administered bimonthly in elderly patients with colorectal cancer. J Clin Oncol 2006; 24:4085-91. (Pubitemid 46622283)
15. Jackson McCleary NA, Meyerhardt J, Green E, et al. Impact of older age on the efficacy of newer adjuvant therapies in>12,500 patients (pts) with stage II/III colon cancer: findings from the ACCENT Database. J Clin Oncol 2009; 27:15s (suppl; abstr 4010).
16. Schrag D, Cramer LD, Bach PB, et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001; 93:850-7. (Pubitemid 32590779)
17. Ayanian JZ, Zaslavsky AM, Fuchs CS, et al. Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort. J Clin Oncol 2003; 21:1293-300. (Pubitemid 46606406)
18. Balducci L. Supportive care in elderly cancer patients. Curr Opin Oncol 2009; 21:310-7.
19. Wallace M, Shelkey M. Katz Index of Independence in Activities of Daily Living (ADL). Urol Nurs 2007; 27:93-4.
20. Graf C. The Lawton Instrumental Activities of Daily Living (IADL) Scale. Medsurg Nurs 2009; 18:315-6.
21. Meropol NJ, Egleston BL, Buzaglo JS, et al. Cancer patient preferences for quality and length of life. Cancer 2008; 113:3459-66.
22. Curley B, O'Grady MA, Litwin S, et al. Assessing the impact of a targeted educational initiative on colorectal cancer lymph node retrieval: a Fox Chase Cancer Center Partners' quality initiative. J Clin Oncol 2009; 27:15s (suppl; abstr 6524).
23. Rajput A, Skibber J, Engstrom P, et al. Meeting the 12 lymph nodes (LN) benchmark in colorectal cancer surgery: a comparison of NCCN and SEER data. J Clin Oncol 2007 ASCO Annual Meeting Proceedings Part I. Vol 25, No. 18S (June 20 Supplement), 2007: 4015
24. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of intergroup trial INT-0089. J Clin Oncol 2003; 21:2912-9. (Pubitemid 46621841)